PTAB Upholds Juxtapid Patents In Hedge Fund Challenge
The Patent Trial and Appeal Board on Monday upheld the validity of two University of Pennsylvania patents related to the cholesterol drug Juxtapid, the latest decisions arising from inter partes reviews...To view the full article, register now.
Already a subscriber? Click here to view full article